Achieving excellence with R&D data will enable the life sciences industry to increase the speed and quality of innovation and is thus a major source of competitive advantage. Whether researchers and informaticians deal with “big data,” “deep data” or just put their data to smarter use, it is clear that the future of R&D is dependent on both smart technologies and clever researchers. The rapid progress of innovation in software and powerful hardware now allows human researchers to interpret masses of amounts of raw data in unique ways and is redefining the R&D business model. The benefits range from discovery and “omics” research, through to clinical trials and to real patients in the real-world. However, it is major technical, financial, and operational challenge to turn “messy” data into structured data, that can be used for advanced analytics that can spot opportunities and achieve true insights. Some of the most promising areas of technological innovation making rapid progress include, for example, artificial intelligence, machine learning, cloud computing and the blockchain (distributed ledgers). There is also huge potential for efficient collaborations between the life science industry, technology companies, academic researchers, health systems, physicians, and health insurers. A deeper convergence between key stakeholders and advanced technologies will facilitate the discovery and development of powerful therapies, devices and advanced diagnostics to benefit patients.

The “R&D Data Intelligence Leaders Forum” is the must attend event for those senior decision-makers, researchers and technologists, looking to make the shift towards an integrated R&D and data strategy and for those looking to improve their implementation of data-driven approaches to enhance R&D decision-making and intelligence.

Request agenda here for complete speaker list

Pharma & Biotech

Global Head Technology, Architecture, Digital Drug Development,
Novartis,Switzerland

Senior Vice President and Head Global Clinical Development, Chief Medical Officer,
Merck Research Labs, USA

CEO
CureVac, Germany

Associate Director, Information Systems
Novartis, Switzerland

Principal Scientist, Scientific Information Management,
Roche, Switzerland

Principal Scientist,
Biogen Idec, USA

Senior GxP IT Auditor,
Bayer, USA

Principal Scientist, Toxicology Project Leader
Roche,Switzerland, (TBC)

Global Head of Real World Evidence Solutions,
Novartis, Switzerland

Senior IT Project Manager Specialized in Health IT,
Roche, Switzerland

Chief Operating Officer,
Cloud Pharmaceuticals, USA

Head of External Technologies & Innovation,
Bayer, Germany

Scientist Bioinformatics
Genentech, USA

Head of Discovery Informatics
e-therapeutics, UK

Senior Fellow; Head Computational Biology and Stats, Target Sciences
GSK R&D, UK

 

Disruptors

CSO,
Numerate, USA

Co-founder,
Insilico Medicine, USA

CEO,
Image Analysis Group, UK

Founder and CEO,
Iktos, France

Co-Founder,
Nebula Genomics, USA

Co-Founder & CEO,
Project Shivom, Germany

CEO,
Evonetix, UK

CTO,
Intellegens, UK

Founder & Managing Director,
GrowthCube Partners, Switzerland

Founder & CEO,
Tonic App, Portugal

Commercial Director,
HealthUnlocked, UK

Co-Founder and CTO
Zebra Medical Vision, Israel

CEO
icometrix, Belgium

Head of Chemoinformatics,
Exscientia, UK

Founder/CEO,
aparito, UK

Co-founder and CEO,
FeetMe, France

Chief Executive Officer, Chief Scientist,
TheraPanacea, France

Partner, Pool Global Partners
Board member, Enlitic, USA

 

MedTech Industry

Principal Scientist - Medical Biomarker Research Oncology,
Philips, Netherlands

CTO,
GE Healthcare, USA, (TBC)

 

Technology Companies

Sr. Program Manager,
Google, USA

CEO,
DNA Nexus, USA

Research Program Manager
Google, Germany

 

Academic Researchers

Distinguished Professor, University of Colorado, & Co-founder,
Amgen, Array BioPharma, USA

Director,Department of Molecular Life Sciences,
University of Zurich, Switzerland

Professor of Clinical Informatics & Healthcare Innovation,
University of Southampton, UK

Centre Head,
Quantitative Biology Center Tübingen, Germany

Professor in Bioinformatics, Director of the Biotechnological center
Technical University Dresden, Germany

 

Independent Thought Leaders

Chair,
European Connected Health Alliance, UK

Founder and CEO,
Lupus Friends and Family Foundation, Chairwoman, EUPATI, Denmark

Managing Director,
Center for Research and Interdisciplinarity (CRI),France

 

Hospitals and Health Systems

Director of Innovation and Development,
NHS Foundation Trust, UK

Chief Technology & Innovation Officer,
Inselgruppe, Bern, Switzerland

Chief Digital Officer and Senior Vice President for Technology Innovation and Consumer Experience,
Thomas Jefferson University and Jefferson Health System, USA

Request agenda here for complete speaker list

Pictures from recent LSDATA Leaders Forums. Imagine being there...

Data is redefining the R&D model and enabling better decision-making and innovation. Senior-level thought leaders from both the R&D and technology perspectives will be presenting the best technologies and approaches of today which are already creating a proven impact in R&D and which will be crucial for the research demands of tomorrow. These speakers will also discuss which technological, financial, regulatory, and operational challenges need to be overcome to ensure that key insights are achieved and that patients’ benefits are dramatically enhanced through R&D intelligence.

Speaker List - Day 1

Distinguished Professor, University of Colorado
& Co-founder Amgen, Array BioPharma, USA

Senior Vice President and Head Global Clinical Development, Chief Medical Officer
Merck Research Labs, USA

Global Head Technology, Architecture, Digital Drug Development
Novartis, Switzerland

CTO
GE Healthcare, USA

Director of Innovation and Development
NHS Foundation Trust, UK

Chief Digital Officer and Senior Vice President for Technology Innovation and Consumer Experience
Thomas Jefferson University and Jefferson Health System, USA

Chief Technology & Innovation Officer
Inselgruppe, Bern, Switzerland

Sr. Program Manager,
Google, USA

CEO
DNA Nexus, USA

One of the key barriers to achieving success in R&D from a dedicated “big” or “deep” data strategy is how to realise R&D potential with the technical capabilities and limitations of IT. The cost of data storage, management, and analysis may be declining rapidly, allowing Big Data to become more realistic than ever, yet which is still an immense challenge. Being able to predict the IT investments into modern infrastructure, advanced software, and high-level security, which will achieve a return on investment is extremely difficult, especially given the wealth of expensive technological options. This stream will analyse the IT possibilities of today and take a peek into the near-future. The audience will also have a chance to hear examples from recent implementations of AI-powered technology within the traditional IT infrastructure. Participants will appreciate how informaticians and technologies can facilitate R&D teams to achieve unique insights into large data sets to increase the intelligence of the whole R&D organization.

Speaker List - Day 2

Associate Director, Information Systems
Novartis, Switzerland

Principal Scientist, Scientific Information Management
Roche, Switzerland

Centre Head
Quantitative Biology Center Tübingen, Germany

Principal Scientist
Biogen, USA

Senior GxP IT Auditor
Bayer, USA

Principal Scientist, Toxicology Project Leader
Roche, Switzerland

This unique day of discussion will bring together 20+ speakers from innovative companies that have potential to disrupt how future medicines are discovered and developed. New and emerging technology approaches such as AI and blockchain have already found their place in R&D innovation and are very likely to have an immensely positive impact on the future of life sciences. Key areas covered in the first half of the day will include AI for drug discovery, AI applications in clinical research and imaging, the intersection of blockchain with genomics research, as well as synthetic biology.

The second part of this day will be focused on Digital Health as the convergence of connected health, m-health, quantified-self, genomics, diagnostics, social media, electronic medical records, and other exciting technologies and trends. Digital health is among the key phenomena driving transformation in the life science industry and in the quest for achieving patient and stakeholder value. This significant paradigm shift within healthcare and the rise of the connected patient is creating vast opportunities for life science innovators to achieve critical insights into patient needs.

Speaker List - Day 2

CSO
Numerate, USA

Co-founder, Insilico Medicine
CSO, The Biogerontology Research Foundation, USA

Head of Chemoinformatics
Exscientia, UK

Chief Operating Officer
Cloud Pharmaceuticals, USA

CTO
Intellegens, UK

Founder and CEO
Iktos, France

CEO
Image Analysis Group, UK

CEO
Evonetix, UK

Co-Founder and CTO
Zebra Medical Vision, Israel

Chief Executive Officer, Chief Scientist
TheraPanacea, France

CEO
icometrix, Belgium

Co-Founder
Nebula Genomics, USA

Co-Founder & CEO
Project Shivom, Germany

Chair
European Connected Health Alliance, UK

Founder & Managing Director
GrowthCube Partners, Switzerland

CEO
Tonic App, Portugal

Co-founder and CEO
FeetMe, France

Founder/ CEO
aparito, UK

This stream will focus on how to plan and implement data-driven approaches in the drug discovery process to unlock innovation. Huge volumes of raw data can be merged with other data sets, structured, and analysed from a myriad of perspectives, not just to achieve answers to complex research questions, but also to develop new hypotheses. Attendees will understand how a dedicated R&D data strategy for precision medicines and large “Omics” data volumes can achieve deep insights that enhance R&D decision making and innovation.

 

Speaker List - Day 3

Head of External Technologies & Innovation
Bayer, Germany

Senior Fellow; Head Computational Biology and Stats, Target Sciences
GSK R&D, UK

Scientist Bioinformatics
Genentech, USA

Head of Discovery Informatics
e-therapeutics, UK

Professor in Bioinformatics, Director of the Biotechnological center
Technical University Dresden, Germany

Principal Scientist - Medical Biomarker Research Oncology
Philips, Netherlands

Distinguished Professor, University of Colorado,
& Co-founder, Amgen, Array BioPharma, USA

CEO
CureVac, Germany

Director,Department of Molecular Life Sciences
University of Zurich, Switzerland

This stream will feature best practice case studies of designing, collecting, and managing large sets of clinical-stage and patient-level data from both clinical and informatics experts. Specific attention will be paid to taking advantage of innovative real-world data generation tools, as well as the potential of new technologies such as blockchain. Key speakers will also present examples of disruptive technologies to develop secure, patient-level data, and build strategic partnerships between key industry players, academia, and patient networks to achieve patient-centric health outcomes.

Speaker List - Day 3

Global Head of Real World Evidence Solutions,
Novartis, Switzerland

Senior IT Project Manager Specialized in Health IT
Roche, Switzerland

Commercial Director
HealthUnlocked, UK

Founder and CEO
Lupus Friends and Family Foundation, Chairwoman, EUPATI, Denmark

Managing Director Center for Research and Interdisciplinarity (CRI),
Board member, Healthcare Data Institute (HDI), France

Professor of Clinical Informatics & Healthcare Innovation
University of Southampton, UK

Research Program Manager
Google, Germany

 

Senior R&D executives: Scientific Officers, Chief Information Officers, Chief Technology Officers, Knowledge & Data Management (Discovery, Clinical & Real-World Data), R&D Analytics, Informatics, R&D Innovation, External Alliances & Innovation, R&D Strategy.

Drug Discovery: Drug Discovery, R&D, Lead Identification & Target Validation, Screening, Translational R&D, Genomics & Proteomics, Biomarker R&D, Senior Scientist, Biostatistics, Biometric, Precision Medicine, Personalised Medicine, Computational Biology.

R&D and IT Infrastructure: Information Technology & Services, R&D IT, IT Hardware & Infrastructure, Software, Database Management, Vendor management

Data Management: Clinical Development, Clinical Data Management, e-Clinical, Electronic Data Management, Health Economics & Outcomes Research, Real-World Evidence Generation, Late-Phase Research, Epidemiology, Drug safety & Pharmacovigilance, Medical Information.

Digital & Connected Health: eHealth, mHealth, Connected Health, Digital Health Solutions, Strategic Medical Innovation, Business Development, Strategic Collaborations, Alliances, External Innovation, Patient Engagement

Platinum Event Partner

Media Partners

Share with Colleagues